Sanofi-Aventis, the fourth-largest pharmaceutical company by prescription sales, Saturday signed a letter of intent with China's Minsheng Pharmaceutical Group on setting up a joint venture that focuses on vitamin and mineral medicines. The new JV will be a strategic platform for Sanofi-Aventis to enter the Chinese...